Citadel Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$450M Sell
3,743,200
-157,400
-4% -$18.2M 0.07% 205
2025
Q4
$411M Buy
3,900,600
+15,200
+0.4% +$1.43M 0.06% 238
2025
Q3
$326M Sell
3,885,400
-560,500
-13% -$46.2M 0.05% 307
2025
Q2
$352M Buy
4,445,900
+847,500
+24% +$67.4M 0.06% 234
2025
Q1
$323M Buy
3,598,400
+2,219,900
+161% +$207M 0.06% 236
2024
Q4
$137M Hold
1,378,500
0.02% 564
2024
Q3
$157M Buy
1,378,500
+132,300
+11% +$15.7M 0.03% 469
2024
Q2
$154M Sell
1,246,200
-482,800
-28% -$62.2M 0.03% 454
2024
Q1
$228M Buy
1,729,000
+389,400
+29% +$48M 0.04% 323
2023
Q4
$146M Sell
1,339,600
-256,800
-16% -$26.7M 0.03% 486
2023
Q3
$164M Sell
1,596,400
-33,400
-2% -$3.6M 0.04% 386
2023
Q2
$188M Sell
1,629,800
-797,900
-33% -$90.6M 0.04% 346
2023
Q1
$258M Sell
2,427,700
-1,857,400
-43% -$201M 0.06% 231
2022
Q4
$475M Buy
4,285,100
+2,135,800
+99% +$218M 0.11% 113
2022
Q3
$185M Sell
2,149,300
-104,300
-5% -$9.31M 0.04% 333
2022
Q2
$205M Buy
2,253,600
+306,700
+16% +$27.2M 0.05% 272
2022
Q1
$160M Sell
1,946,900
-1,564,500
-45% -$123M 0.03% 441
2021
Q4
$269M Buy
3,511,400
+1,541,000
+78% +$123M 0.06% 249
2021
Q3
$148M Buy
1,970,400
+459,100
+30% +$34.9M 0.03% 465
2021
Q2
$118M Sell
1,511,300
-80,298
-5% -$5.97M 0.03% 578
2021
Q1
$117M Sell
1,591,598
-188,744
-11% -$13.9M 0.03% 516
2020
Q4
$139M Buy
1,780,342
+338,713
+23% +$25.9M 0.04% 396
2020
Q3
$114M Sell
1,441,629
-96,101
-6% -$7.53M 0.03% 400
2020
Q2
$113M Sell
1,537,730
-515,512
-25% -$38.8M 0.04% 352
2020
Q1
$151M Buy
2,053,242
+156,152
+8% +$12.3M 0.07% 205
2019
Q4
$165M Sell
1,897,090
-93,376
-5% -$7.67M 0.07% 224
2019
Q3
$160M Buy
1,990,466
+438,797
+28% +$35.2M 0.08% 216
2019
Q2
$124M Sell
1,551,669
-1,334,523
-46% -$102M 0.06% 307
2019
Q1
$229M Buy
2,886,192
+437,540
+18% +$32.7M 0.11% 117
2018
Q4
$179M Buy
2,448,652
+931,462
+61% +$65.8M 0.1% 142
2018
Q3
$103M Buy
1,517,190
+163,384
+12% +$10.4M 0.05% 404
2018
Q2
$78.4M Sell
1,353,806
-201,950
-13% -$11.4M 0.04% 467
2018
Q1
$80.9M Sell
1,555,756
-347,726
-18% -$18.8M 0.04% 400
2017
Q4
$102M Buy
1,903,482
+1,364,181
+253% +$75.6M 0.06% 323
2017
Q3
$33M Sell
539,301
-289,353
-35% -$17.5M 0.03% 765
2017
Q2
$50.7M Sell
828,654
-11,108
-1% -$676K 0.04% 486
2017
Q1
$50.9M Sell
839,762
-286,209
-25% -$17.4M 0.05% 442
2016
Q4
$63.3M Buy
1,125,971
+330,853
+42% +$19.4M 0.06% 297
2016
Q3
$47.4M Buy
795,118
+355,482
+81% +$20.8M 0.05% 409
2016
Q2
$24.2M Buy
439,636
+9,956
+2% +$530K 0.03% 653
2016
Q1
$21.7M Buy
429,680
+125,341
+41% +$6.14M 0.03% 696
2015
Q4
$15.3M Sell
304,339
-233,180
-43% -$11.8M 0.02% 999
2015
Q3
$25.3M Buy
537,519
+117,481
+28% +$6.24M 0.02% 749
2015
Q2
$22.8M Sell
420,038
-44,331
-10% -$2.49M 0.02% 915
2015
Q1
$25.5M Buy
464,369
+128,904
+38% +$7.3M 0.02% 833
2014
Q4
$18.2M Sell
335,465
-35,108
-9% -$1.96M 0.02% 1008
2014
Q3
$21M Buy
370,573
+86,251
+30% +$4.84M 0.02% 878
2014
Q2
$15.7M Sell
284,322
-225,844
-44% -$12.3M 0.02% 967
2014
Q1
$27.6M Sell
510,166
-107,525
-17% -$5.57M 0.03% 646
2013
Q4
$29.5M Sell
617,691
-239,783
-28% -$11M 0.04% 598
2013
Q3
$39M Buy
857,474
+92,120
+12% +$4.21M 0.06% 398
2013
Q2
$33.9M Buy
+765,354
New +$34.2M 0.06% 392

Other funds holding MRK

Citadel Advisors's MRK Position: Q1 2026 in Review

Citadel Advisors reduced its Merck (MRK) stake by 44% in Q1 2026, selling an estimated $346M and leaving 3,821,227 shares worth $460M. The position accounts for 0.07% of the portfolio, ranked #197.

Citadel Advisors first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.02B in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Citadel Advisors held 3,821,227 shares of Merck worth $460M as of Q1 2026.
  • Citadel Advisors sold 3,000,104 Merck shares in Q1 2026, an estimated $346M.
  • Merck made up 0.07% of Citadel Advisors's portfolio in Q1 2026, its #197 holding.
  • Citadel Advisors first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Merck position peaked at $1.02B in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.